Vertex Pharmaceuticals Incorporated (VRTX)
Market Closed
10 Aug, 20:00
$
523. 91
+27.84
+5.6121%
$
121.5B Market Cap
30.83 P/E Ratio
- Div Yield
2.67M Volume
14.94 Eps
$ 496.07
Previous Close 
Want to track VRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vertex Pharmaceuticals Incorporated (VRTX) Statistics
Valuation metrics
Market Cap 121.5B
Enterprise value 119.76B
Trailing P/E (ttm) 28.64
Forward P/E 19.95
PEG ratio 1.27
Price/Sales (ttm) 9.97
Price/Book (mrq) 6.22
Enterprise Value/Revenue 9.49
Enterprise Value/EBITDA 22
Overview
Shares outstanding 254.16M
Float 253.02M
Shares short 4.17M
% Held by insiders 0%
% Held by institutions 0.98%
Average volume (10 days) 1.32M
Average volume (90 days) 1.4M
Price summary
52-Week low 362.5
52-Week high 546.17
Beta 0.3
50-Day moving average 491.29
200-Day moving average 459.52
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 24 Aug 2000
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.35%
Operating margin 0.39%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.23%
Income Statement
Revenue (ttm) 12.22B
Revenue per share (ttm) 49.72
Quarterly revenue growth (yoy) 0.08%
Gross profit (ttm) 6.65B
EBITDA 5.26B
Net income to common (ttm) 4.34B
Diluted EPS (ttm) 17.35
Quarterly earnings growth (yoy) 0.6%
Balance Sheet
Total cash (mrq) 7.25B
Total cash per share (mrq) 30.93
Total debt (mrq) 1.99B
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 3.19%
Book value per share (mrq) 79.75
Cash Flow
Cash flow statement 4.24B
Levered free cash flow (LFCF) 2.78B
